496
Views
9
CrossRef citations to date
0
Altmetric
Review

Postmenopausal endometriosis: drawing a clearer clinical picture

&
Pages 249-255 | Received 01 Dec 2017, Accepted 28 Feb 2018, Published online: 03 Apr 2018

References

  • Fagervold B, Jenssen M, Hummelshoj L, Moen MH. Life after a diagnosis with endometriosis–a 15 years follow-up study. Acta Obstet Gynecol Scand 2009;88:914–19
  • Punnonen R, Klemi PJ, Nikkanen V. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol 1980;11:195–200
  • Haas D, Chvatal R, Reichert B, et al. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet 2012;286:667–70
  • Bendon CL, Becker CM. Potential mechanisms of postmenopausal endometriosis. Maturitas 2012;72:214–19
  • Streuli I, Gaitzsch H, Wenger JM, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric 2017;20:138–43
  • Brosens I, Puttemans P, Benagiano G. Endometriosis: a life cycle approach?. Am J Obstet Gynecol 2013;209:307–16
  • Shah D. Postmenopausal endometriosis: an enigma revisited. J Midlife Health 2014;5:163–4
  • Toki T, Horiuchi A, Li SF, Nakayama K, Silverberg SG, Fujii S. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunocytochemical study. Int J Gynecol Pathol 1996;15:45–53
  • Cumiskey J, Whyte P, Kelehan P, Gibbons D. A detailed morphologic and immunohistochemical comparison of pre- and postmenopausal endometriosis. J Clin Pathol 2008;61:455–59
  • Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S. Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 2002;955:75–85
  • Bulun SE, Fang Z, Imir G, et al. Aromatase and endometriosis. Semin Reprod Med 2004;22:45–50
  • Bulun SE. Endometriosis. N Engl J Med 2009;360:268–79
  • Noble LS, Takayama K, Zeitoun KM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997;82:600–6
  • Morotti M, Remorgida V, Venturini PL, Ferrero S. Endometriosis in menopause: a single institution experience. Arch Gynecol Obstet 2012;286:1571–5
  • Noel JC, Anaf V, Fayt I, Wespes E. Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation. Arch Gynecol Obstet 2006;274:389–92
  • Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A. Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev 2009;(1):CD005997
  • Matorras R, Elorriaga MA, Pijoan JI, Ramón O, Rodríguez-Escudero FJ. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril 2002;77:303–8
  • Matsuura K, Ohtake H, Katabuchi H, Okamura H. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest 1999;47(Suppl 1):18–20
  • Rosa-e-Silva JC, Carvalho BR, Barbosa Hde F, et al. Endometriosis in postmenopausal women without previous hormonal therapy: report of three cases. Climacteric 2008;11:525–8
  • Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001;20:133–9
  • Brinton LA, Sakoda LC, Sherman ME, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 2005;14:2929–35
  • Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925;10:1–72
  • Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest 2000;50(Suppl 1):18–25
  • Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 2009;14:378–82
  • Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 2002;100:788–95
  • Kobayashi H, Sumimoto K, Kitanaka T, et al. Ovarian endometrioma–risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 2008;138:187–93
  • Kawaguchi R, Tsuji Y, Haruta S, et al. Clinicopathologic features of ovarian cancer in patients with ovarian endometrioma. J Obstet Gynaecol Res 2008;34:872–7
  • Shen YM, Wu XL, Xu L, et al. Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases. Ai Zheng 2008;27:1106–10
  • Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572–9
  • Melin A, Sparén P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21:1237–42
  • Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 2000;79:18–22
  • Soliman NF, Hillard TC. Hormone replacement therapy in women with past history of endometriosis. Climacteric 2006;9:325–35
  • Karanjgaokar VC, Murphy DJ, Samra JS, Mann CH. Malignant transformation of residual endometriosis after hysterectomy: a case series. Fertil Steril 2009;92:2037.e19–2021
  • Cohen I, Altaras MM, Lew S, Tepper R, Beyth Y, Ben-Baruch G. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol Oncol 1994;55:443–7
  • McCluggage WG, Bryson C, Lamki H, Boyle DD. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 2000;19:276–9
  • Okugawa K, Hirakawa T, Ogawa S, Kaku T, Nakano H. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report. Gynecol Oncol 2002;87:231–4
  • Bese T, Simsek Y, Bese N, Ilvan S, Arvas M. Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women. Int J Gynecol Cancer 2003;13:376–80
  • Leiserowitz GS, Gumbs JL, Oi R, et al. Endometriosis-related malignancies. Int J Gynecol Cancer 2003;13:466–71
  • Popoutchi P, dos Reis Lemos CR, Silva JC, Nogueira AA, Feres O, Ribeiro da Rocha JJ. Postmenopausal intestinal obstructive endometriosis: case report and review of the literature. Sao Paulo Med J 2008;126:190–3
  • Wolthuis AM, Meuleman C, Tomassetti C, D'Hooghe T, de Buck van Overstraeten A, D'Hoore A. Bowel endometriosis: colorectal surgeon’s perspective in a multidisciplinary surgical team. World J Gastroenterol 2014;20:15616–23
  • Inceboz U. Endometriosis after menopause. Womens Health (Lond) 2015;11:711–15
  • Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol 2011;9:90
  • Barbieri RL. Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment. J Reprod Med 1998;43(3 Suppl):287–92
  • Oxholm D, Knudsen UB, Kryger-Baggesen N, Ravn P. Postmenopausal endometriosis. Acta Obstet Gynecol Scand 2007;86:1158–64
  • Fedele L, Bianchi S, Raffaelli R, Zanconato G. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas 1999;32:189–93
  • Moen MH, Rees M, Brincat M, European Menopause and Andropause Society, et al. EMAS position statement: Managing the menopause in women with a past history of endometriosis. Maturitas 2010;67:94–7
  • Dunselman GA, Vermeulen N, Becker C, European Society of Human Reproduction and Embryology, et al. ESHRE guideline: management of women with endometriosis. Maturitas 2014;29:400–12
  • Gemmell LC, Webster KE, Kirtley S, Vincent K, Zondervan KT, Becker CM. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update 2017;23:481–500
  • Baber RJ, Panay N, Fenton A. IMS Writing Group. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American menopause society. Menopause 2017;24:728–53
  • Cobin RH, Goodman NF. AACE Reproductive Endocrinology Scientific Committee. American Association of clinical endocrinologists and American college of endocrinology position statement on menopause – 2017 update. Endocr Pract 2017;23:869–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.